GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Mar. 2016 was $-1,309 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2016 was $-5,828 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
GlaxoSmithKline PLC's quarterly payment of dividends declined from Sep. 2015 ($-1,459 Mil) to Dec. 2015 ($-1,329 Mil) and declined from Dec. 2015 ($-1,329 Mil) to Mar. 2016 ($-1,309 Mil).
GlaxoSmithKline PLC's annual payment of dividends declined from Dec. 2012 ($-6,162 Mil) to Dec. 2013 ($-6,023 Mil) and declined from Dec. 2013 ($-6,023 Mil) to Dec. 2014 ($-6,014 Mil).
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
GlaxoSmithKline PLC Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2016 was -1730.52959502 (Jun. 2015 ) + -1458.58895706 (Sep. 2015 ) + -1329.34131737 (Dec. 2015 ) + -1309.11680912 (Mar. 2016 ) = $-5,828 Mil.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data